Pharmacological and biochemical interactions between opioids and cannabinoids

Trends in Pharmacological Sciences

Volumn 20, Issue 7, 1999, Pages 287-294

  Manzanares, Jorge ^c   Corchero, Javier ^c   Romero, Julian ^c   Fernández Ruiz, Javier J ^c   Ramos, José A ^b   Fuentes, José A ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; BETA FUNALTREXAMINE; CANNABINOID; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABIS; DIAMORPHINE; DRONABINOL; DYNORPHIN; DYNORPHIN B; MORPHINE; NALOXONE; NORBINALTORPHIMINE; OPIATE; OPIATE ANTAGONIST; OPIATE RECEPTOR; RIMONABANT;

ANTINOCICEPTION; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG DEPENDENCE; DRUG POTENTIATION; HUMAN; NONHUMAN; PAIN; PRIORITY JOURNAL; REVIEW; WITHDRAWAL SYNDROME;

CANNABINOIDS; DRUG INTERACTIONS; HUMANS; NARCOTICS; NOCICEPTORS; SUBSTANCE-RELATED DISORDERS;

EID: 0343718836     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(99)01339-5     Document Type: Review

References (38)

1. Dewey W.L. Pharmacol. Rev. 38:1986;151-178.
2. Holdcroft A.et al. Anaesthesia. 52:1997;483-486.
3. Notcutt W., Price M., Chapman G. Pharm. Sci. 3:1997;551-555.
4. Lichtman A.H., Martin B.R. J. Pharmacol. Exp. Ther. 258:1991;517-523.
5. Martin W.J., Lai N.K., Patrick S.L., Tsou K., Walker J.M. Brain Res. 629:1993;300-304.
6. Martin W.J., Patrick S.L., Coffin P.O., Tsou K., Walker J.M. Life Sci. 56:1995;2103-2109.
7. Calignano A., La Rana G., Giuffrida A., Piomelli D. Nature. 394:1998;277-281.
8. Stein C., Schafer M., Hassan A.H. Ann. Med. 27:1995;219-221.
9. Stein C., Yassouridis A. Pain. 71:1997;119-121.
10. Nakamura M., Ferreira S.H. Eur. J. Pharmacol. 146:1988;223-228.
11. Smith P.B., Martin B.R. Brain Res. 578:1992;8-12.
12. Hohmann A.G., Herkenham M. Neurosci. Lett. 252:1998;13-16.
13. Reche I., Fuentes J.A., Ruiz-Gayo M. Eur. J. Pharmacol. 301:1996;75-81.
14. Reche I., Fuentes J.A., Ruiz-Gayo M. Eur. J. Pharmacol. 318:1996;11-16.
15. Lu Y., Pirec V., Yeomans D.C. Br. J. Pharmacol. 121:1997;1210-1216.
16. Laughlin T.M.et al. Pain. 72:1997;253-260.
17. Pugh G. Jr., Mason D.J. Jr., Combs V., Welch S.P. J. Pharmacol. Exp. Ther. 281:1997;730-737.
18. Pugh G. Jr., Smith P.B., Dombrowski D.S., Welch S.P. J. Pharmacol. Exp. Ther. 279:1996;608-616.
19. Smith P.B., Welch S.P., Martin B.R. J. Pharmacol. Exp. Ther. 268:1994;1381-1387.
20. Rowen D.W., Embrey J.P., Moore C.H., Welch S.P. Pharmacol. Biochem. Behav. 59:1998;399-404.
21. Pugh G. Jr., Abood M.E., Welch S.P. Brain Res. 698:1995;157-158.
22. Lichtman A.H., Martin B.R. Brain Res. 559:1991;309-314.
23. Welch S.P., Huffman J.W., Lowe J. J. Pharmacol. Exp. Ther. 286:1998;1301-1308.
24. Lichtman A.H., Cook S.A., Martin B.R. J. Pharmacol. Exp. Ther. 276:1996;585-593.
25. Martin W.J., Tsou K., Walker J.M. Neurosci. Lett. 242:1998;33-36.
26. Martin W.J., Hohmann A.G., Walker J.M. J. Neurosci. 16:1996;6601-6611.
27. Meng I.D., Manning B.H., Martin W.J., Fields H.L. Nature. 395:1998;381-383.
28. Herkenham M.et al. J. Neurosci. 11:1991;563-583.
29. Melvin L.S.et al. Mol. Pharmacol. 44:1993;1008-1013.
30. Lichtman A.H., Martin B.R. Pharmacol. Biochem. Behav. 57:1997;7-12.
31. Edsall S.A.et al. NeuroReport. 7:1996;593-596.
32. Richardson J.D., Aanonsen L., Hargreaves K.M. Eur. J. Pharmacol. 319:1997;R3-R4.
33. Smith F.L., Fujimori K., Lowe J., Welch S.P. Pharmacol. Biochem. Behav. 60:1998;183-191.
34. Jaggar S.I., Hasnie F.S., Sellaturay S., Rice A.S. Pain. 76:1998;189-199.
35. Welch S.P., Dunlow L.D., Patrick G.S., Razdan R.K. J. Pharmacol. Exp. Ther. 273:1995;1235-1244.
36. Adams I.B., Compton D.R., Martin B.R. J. Pharmacol. Exp. Ther. 284:1998;1209-1217.
37. Welch S.P. Drug Alcohol Depend. 45:1997;39-45.
38. Richardson J.D., Kilo S., Hargreaves K.M. Pain. 75:1998;111-119.